eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive About the journal Special Issues Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 104
Original paper

Clinical evaluation of omega-3 fatty acids in psoriasis

Mohammad Adil, Pramod Kumar Singh, Kopal Maheshwari

Dermatol Rev/Przegl Dermatol 2017, 104, 314–323
Online publish date: 2017/07/05
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Introduction. Omega-3 fatty acids are largely derived from fish oils and are known to decrease inflammation. There have been a few small studies showing the beneficial effect of omega-3 fatty acids in psoriasis.

Objective. To evaluate the efficacy of omega-3 fatty acids in conjunction with emollients in patients with mild to moderate chronic plaque psoriasis.

Materials and methods. A total of 200 clinically diagnosed cases of chronic plaque psoriasis with less than 10% of body surface area involvement were recruited and divided into group A and group B. Group A was given 1,800 mg daily of omega-3 fatty acids in three divided oral doses and topical paraffin over the lesions. Group B was prescribed only topical paraffin. At the end of 12 weeks, treatment response was assessed by means of Psoriasis Area Severity Index (PASI), and by its components including area involved, erythema, induration and desquamation scores.

Results. The mean PASI score changed from 7.44 to 3.96 in group A, and from 7.24 to 5.19 in group B. There was a statistically significant difference in PASI, erythema, induration, desquamation scores and area involved between the two groups after 12 weeks. Forty four (46.3%) patients in group A and 13 (13.9%) patients in group B achieved a 50% or more reduction in PASI scores.

Conclusions. Omega-3 fatty acids in conjunction with topical emollients appear to reduce the severity of psoriasis with no major side effects. The combination can be a useful adjunct to other psoriasis treatments.

psoriasis, omega-3, fish oils

Griffiths C., Barker J.N.: Psoriasis. [in:] Rook’s textbook of dermatology. 8th ed. T. Burns, S. Brethnach, N. Cox, C. Griffiths (eds.). Blackwell Publishing, West Sussex, 2010, 1-22.
Gudjonsson J.E., Elder J.T.: Psoriasis. [in:] Fitzpatrick’s dermatology in general medicine. 8th ed. L.A. Goldsmith, S.I. Katz, B.A. Gilchrest, A.S. Paller, D.J. Leffel, K. Wolff (eds.). McGraw Hill, New York, 2012, 197-224.
Kagami S., Rizzo H.L., Lee J.J., Koguchi Y., Blauvelt A.: Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 2010, 130, 1373-1383.
Love T.J., Qureshi A.A., Karlson E.W., Gelfand J.M., Choi H.K.: Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003–2006. Arch Dermatol 2011, 147, 419-424.
Cakmur H., Dervis E.: The relationship between quality of life and the severity of psoriasis in Turkey. Eur J Dermatol 2015, 25, 169-176.
Traub M., Marshall K.: Psoriasis – pathophysiology, conventional and alternative approaches to treatment. Alt Med Rev 2007, 12, 319-330.
Laddha G.P., Vidyasagar G., Bavaskar S.R., Bhole N.: Omega-3 fatty acid: living longer happier from complexities. Int J Pharm Bio Sci 2012, 2, 60-75.
Calder P.C.: Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 2009, 91, 791-795.
van Onselen J.: An overview of psoriasis and the role of emollient therapy. Br J Community Nurs 2013, 18, 174-179.
Guida B., Napoleone A., Trio R., Nastasi A., Balato N., Laccetti R., et al.: Energy restricted, n-3 polyunsaturated fatty acids-rich diet improves the clinical response to immuno-modulating drugs in obese patients with plaque-type psoriasis: a randomized control clinical trial. Clin Nutr 2014, 33, 399-405.
Mari N.L., Simao A.M.C., Dichi I.: n-3 polyunsaturated fatty acids supplementation in psoriasis: a review. Nutrire 2017, 42, 5.
Escobar S.O., Achenbach R., Iannantuono R., Torem V.: Topical fish oil in psoriasis – a controlled and blind study. Clin Exp Dermatol 1992, 17, 159-162.
Soyland E., Funk J., Rajka G., Sandberg M., Thune P., Rustad L., et al.: Effect of dietary supplementation with very long chain n-3 fatty acids in patients with psoriasis. N Eng J Med 1993, 328, 1812-1816.
Grimminger F., Mayser P., Papavassilis C., Thomas M., Schlotzer E., Heuer K.U., et al.: A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile. Clin Invest 1993, 71, 634-643.
Mayser P., Mrowietz U., Arenberger P., Bartak P., Buchvald J., Christophers E., et al.: Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol 1998, 38, 539-547.
Mayser P., Grimm H., Grimminger F.: N-3 fatty acids in psoriasis. Br J Nutr 2002, 87 Suppl 1, 77-82.
Zulfakar M.H., Edwards M., Heard C.M.: Is there a role for topically delivered eicosapentaenoic acid in the treatment of psoriasis? Eur J Dermatol 2007, 17, 284-291.
Balbás G.M., Regana M.S., Millet P.U.: Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis. Clin Cosmet Investig Dermatol 2011, 4, 73-77.
Assessing a psoriasis patient. [in:] Psoriasis and psoriatic arthritis pocket guide: treatment algorithms and management guide. 3rd ed. A.V. Voorhees, S.R. Feldman, J.Y.M. Koo, M.G. Lebwohl, A. Menter A (eds.). National Psoriasis Foundation, Portland, 2009, 9-44.
Puzenat E., Bronsard V., Prey S., Gourraud P.A., Aractingi S., Bagot M., et al.: What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol 2010, 24, 10-16.
Carlin C.S., Feldman S.R., Kreuger J.G., Menter A., Krueger G.G.: A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol 2004, 50, 859-866.
Kurd S.K., Gelfand J.M.: The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009, 60, 218-224.
Dogra S., Yadav S.: Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol 2010, 76, 595-601.
Mabuchi T., Ota T., Manabe Y., Ikoma N., Ozawa A., Terui T., et al.: HLA-C*12:02 is a susceptibility factor in late-onset type of psoriasis in Japanese. J Dermatol 2014, 41, 697-704.
Puri N., Mahajan B.B., Sandhu S.K.: Clinical evaluation of different therapeutic modalities in psoriasis by PASI score. Our Dermatol Online 2013, 4, 16-22.
Arican O., Aral M., Sasmaz S., Ciragil P.: Serum levels of TNF-αlpha, IFN- gamma, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005, 24, 273-279.
Lassus A., Dahlgren A.L., Halpern M.J., Santalahti J., Happonen H.P.: Effects of dietary supplementation with polyunsaturated ethyl ester lipids (Angiosan) in patients with psoriasis and psoriatic arthritis. J Int Med Res 1990, 18, 68-73.
Bittner S.B., Cartwright I., Tucker W.F., Bleehen S.S.: A double blind randomized placebo controlled trial of fish oil in psoriasis. Lancet 1988, 20, 378-380.
Gupta A.K., Ellis C.N., Tellner D.C., Anderson T.F., Voorhees J.J.: Double blind placebo controlled study to evaluate the efficacy of fish oil and low dose UVB in the treatment of psoriasis. Br J Dermatol 1989, 120, 801-807.
Kragballe K., Fogh K.: A low-fat diet supplemented with dietary fish oil results in improvement of psoriasis and in formation of leukotriene B5. Acta Derm Venerol 1989, 69, 23-28.
Rahman M., Beg S., Anwar F., Kumar V.: [in:] Omega-3 fatty acids. Beneficial effect of long chain omega-3 fatty acids in psoriasis. M.V. Hodge, A.V. Zanwar, S.P. Adekar (eds.). Springer, 2016, 531-540.
Upala S., Yong W.C., Theparee T., Sanguankeo A.: Effect of omega-3 fatty acids on disease severity in patients with psoriasis: a systematic review. Int J Rheum Dis 2017, 20, 442-450.
Gupta A.K., Ellis C.N., Goldfarb M.T.: The role of fish oils in psoriasis: a randomized double blind placebo controlled study to evaluate the effect of fish oils and topical corticosteroid therapy in psoriasis. Int J Dermatol 1990, 29, 591-597.
Henneicke-von Zepelin H.H., Mrowietz U., Färber L., Bruck-Borchers K., Schober C., Huber J., et al.: Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicenter study. Br J Dermatol 1993, 129, 713-717.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe